Search Results - "Tsirakis, G."

Potential role of FLT3-ligand in the angiogenic process of multiple myeloma by Kokonozaki, M, Tsirakis, G, Devetzoglou, M, Kyriakaki, S, Antonakis, A, Vyzoukaki, R, Pappa, C.A, Tzardi, M, Alexandrakis, M.G

“…Highlights • FLT3-L is implicated in MM angiogenesis. • Serum levels of FLT3-L can be used as angiogenic markers MM. • Serum levels of FLT3-L may serve as…”
Get full text

B cell-activating factor: its clinical significance in multiple myeloma patients by Fragioudaki, M., Boula, A., Tsirakis, G., Psarakis, F., Spanoudakis, M., Papadakis, I. S., Pappa, C. A., Alexandrakis, M. G.

“…B cell-activating factor (BAFF) is a cytokine that plays a major role in the maintenance of normal B-cell development and homeostasis. It has been suggested…”
Get full text

P22: A NON‐INTERVENTIONAL, PROSPECTIVE, OBSERVATIONAL STUDY OF RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IXAZOMIB IN REAL‐WORLD SETTINGS IN GREECE; INTERIM RESULTS OF THE ‘OL‐ORAL’ STUDY by Katodritou, E, Kyrtsonis, MC, Delimpasi, S, Spanoudakis, E, Vassilopoulos, G, Zikos, P, Viniou, N, Kaiafa, G, Papathanasiou, M, Pappa, V, Michalis, E, Adamopoulos, I, Kokoviadou, K, Tsirakis, G, Poziopoulos, C, Terpos, E

Get full text

Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma by Fragioudaki, M, Tsirakis, G, Pappa, C.A, Aristeidou, I, Tsioutis, C, Alegakis, A, Kyriakou, D.S, Stathopoulos, E.N, Alexandrakis, M.G

“…Abstract B-cell activating factor (BAFF) is a B-cell growth factor. We measured its serum levels and correlated them with parameters of disease activity, as…”
Get full text

P1646: PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN PATIENTS OLDER THAN 75 YEARS: REAL WORLD DATA FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY by Pontikoglou, C., Matheakakis, A., Stavroulaki, E., Chatzilygeroudi, T., Kourakli, A., Symeonidis, A., Dimou, M., Panayiotidis, P., Drakos, G., Koudouna, A., Galanopoulos, A., Kaliafentaki, V., Kanellou, P., Liapi, D., Tsirakis, G., Kolovou, A., Gavriilaki, E., Syrigou, A., Sakellari, I., Chatzileontiadou, S., Papaioannou, M., Bobola, M., Diamantopoulos, P., Mantzourani, M., Viniou, N.‐A., Dellatola, M., Souravla, A., Pagoni, M., Megalakaki, A., Christodoulou, I., Vlachaki, E., Giannouli, S., Gkalea, V., Matsouka, C., Kotsianidis, I., Vassilopoulos, G., Protopappa, M., Hatzimichael, E., Zikos, P., Chalkiadakis, G. N., Papadaki, H. A.

Get full text

Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity by Alexandrakis, M. G., Pappa, C. A., Kokonozaki, M., Boula, A., Vyzoukaki, R., Staphylaki, D., Papadopoulou, A., Androulakis, N., Tsirakis, G., Sfiridaki, A.

“…Angiogenesis is an important hallmark in multiple myeloma (MM) pathogenesis, with the participation of various versatile molecules. Interleukin-20 (IL-20) is a…”
Get full text

Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma by Pappa, C.A., Tsirakis, G., Kanellou, P., Kaparou, M., Stratinaki, M., Xekalou, A., Alegakis, A., Boula, A., Stathopoulos, E.N., Alexandrakis, M.G.

“…► ELR+ motif CXC chemokines (IL-8, ENA-78 and GRO-α) correlate with angiogenic activity in multiple myeloma. ► GRO-α showed a distinct angiogenic profile as…”
Get full text

Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment by Sfiridaki, K., Pappa, C. A., Tsirakis, George, Kanellou, Peggy, Kaparou, Maria, Stratinaki, M., Sakellaris, G., Kontakis, G., Alexandrakis, Michael G.

“…An essential cytokine system for the osteoclast biology in multiple myeloma (MM) consists of the receptor of activator of NF-κB ligand (RANKL), its receptor…”
Get full text

Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-α in multiple myeloma by Pappa, C. A., Tsirakis, G., Devetzoglou, M., Zafeiri, M., Vyzoukaki, R., Androvitsanea, A., Xekalou, A., Sfiridaki, K., Alexandrakis, M. G.

“…Angiogenesis is a crucial process in growth and progression of multiple myeloma (MM). Mast cells (MCs) play an important role in MM angiogenesis. Various…”
Get full text

Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients by Pappa, CA, Alexandrakis, MG, Boula, A, Psarakis, FE, Kolovou, A, Bantouna, V, Stavroulaki, E, Tsirakis, G

“…Angiogenesis is an essential process for the expansion of multiple myeloma (MM), in which many angiogenic factors participate. Endoglin (CD105) is a…”
Get full text

Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma by Tsirakis, G., Pappa, C. A., Psarakis, F. E., Fragioudaki, M., Tsioutis, C., Stavroulaki, E., Boula, A., Alexandrakis, M. G.

“…Multiple myeloma (MM) is a disease of plasma cells that express the CD40 receptor. Binding of the CD40 by its natural ligand, CD40 ligand (CD40L), produces…”
Get full text

Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma by Tsirakis, G, Pappa, C.A, Spanoudakis, M, Chochlakis, D, Alegakis, A, Psarakis, F.E, Stratinaki, M, Stathopoulos, E.N, Alexandrakis, M.G

“…Abstract Background Τhe importance of angiogenesis in malignancies' growth is well recognized. CD105 (Endoglin), a proliferation-associated glycoprotein, is a…”
Get full text

Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients by Tsirakis, G, Pappa, C A, Kaparou, M, Katsomitrou, V, Hatzivasili, A, Alegakis, T, Xekalou, A, Stathopoulos, E N, Alexandrakis, M G

“…Multiple myeloma (MM) is a malignant plasma cell disease. Several proinflammatory cytokines produced by malignant plasma cells and bone marrow (BM) stromal…”
Get full text

Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma by Pappa, C. A., Tsirakis, G., Psarakis, F. E., Kolovou, A., Tsigaridaki, M., Stafylaki, D., Sfiridaki, K., Alexandrakis, M. G.

“…There are many growth factors influencing the expansion of multiple myeloma (MM). Angiogenesis is a process that may enhance MM growth, in various manners…”
Get full text

Serum levels of Interleukin-15 and Interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma by Pappa, C., Miyakis, S., Tsirakis, G., Sfiridaki, A., Alegakis, A., Kafousi, M., Stathopoulos, E.N., Alexandrakis, M.G.

“…In order to determine prognostic factors characterizing multiple myeloma (MM) cell kinetics, bone marrow proliferative activity and serum Interleukin-10…”
Get full text

P103 Iron chelation treatment in patients with myelodysplastic syndromes (MDS): the experience of the Hellenic MDS Study Group by Kouraklis, A, Symeonidis, A, Galanopoulos, A, Kaiafa, G, Tavernarakis, I, Tsirakis, G, Michali, E, Tsaftaridis, P, Loukidis, K, Aggelidis, A, Zoumbos, N

Get full text

Serum levels of leptin in multiple myeloma patients and its relation to angiogenic and inflammatory cytokines by ALEXANDRAKIS, M. G, PASSAM, F. H, SFIRIDAKI, A, PAPPA, C. A, MOSCHANDREA, J. A, KANDIDAKI, E, TSIRAKIS, G, KYRIAKOU, D. S

“…Leptin, apart from the regulation of food intake, has been implicated in hematopoiesis, the immune response and angiogenesis. Leptin has been found to be…”
Get full text

Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance by PASSAM, F. H., TSIRAKIS, G., BOULA, A., FRAGOU, A., CONSOLAS, I., ALEGAKIS, A., KYRIAKOU, D. S., ALEXANDRAKIS, M. G.

“…Summary The aim of this study was to assess circulating soluble intercellular adhesion molecule‐1 (sICAM‐1), soluble vascular cell adhesion molecule‐1…”
Get full text

Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-[alpha] in multiple myeloma by Pappa, C A, Tsirakis, G, Devetzoglou, M, Zafeiri, M, Vyzoukaki, R, Androvitsanea, A, Xekalou, A, Sfiridaki, K, Alexandrakis, M G

“…Angiogenesis is a crucial process in growth and progression of multiple myeloma (MM). Mast cells (MCs) play an important role in MM angiogenesis. Various…”
Get full text

PF693 PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN THE ELRDELRY AND YOUNGER ADULTS: REAL‐WORLD COMPARATIVE RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY by Pontikoglou, C., Kaliafentaki, V., Stavroulaki, E., Tzikoulis, V., Kanellou, P., Symeonidis, A., Patrinos, A., Kourakli, A., Chatzilygeroudi, T., Panayiotidis, P., Viniou, N.‐A., Matzourani, M., Dimou, M., Galanopoulos, A., Chondropoulos, S., Roubakis, C., Liapi, D., Kolovou, A., Tsirakis, G., Anagnostopoulos, A., Syrigou, A., Gavriilaki, E., Megalakaki, A., Lampropoulou, P., Vlachaki, E., Christodoulou, I., Papaioannou, M., Gogou, V., Bobola, M., Giannouli, S., Kotsianidis, I., Vassilopoulos, G., Protopappa, M., Hatzimichael, E., Zikos, P., Chalkiadakis, G., Papadaki, H.A.

“…Background: As life expectancy increases, elderly patients (pts) with immune thrombocytopenia (ITP) are increasingly being encountered in everyday practice…”
Get full text